Generalfox.com

Advanced Science Topics and Thought

Generalfox.com

Many researchers, politicians, scientists, and regular people have wondered why there has been such a big push to use these mRNA “vaccines” – why alternate “treatments” were not seemingly equally pushed as hard to provide relief, or best yet, an actual ‘cure’. I offer a few that I have stumbled across on the Internet below. A reminder that the definition of a Vaccine was changed to accommodate calling these mRNA products Vaccines.

Natural Immunity

Not sure why this is being downplayed? With the true death rates of COVID-19 being essentially equal to seasonal influenza (which we’ve been dealing with for hundreds of years) no studies have been performed by the US National Health Institute on the benefits and efficiency of natural immunity. A 700,000-person study from Israel found that those who had experienced prior infections were 27 times less likely to get a second symptomatic covid infection than those who were vaccinated. This affirmed a Cleveland Clinic study of health-care workers (often exposed to the virus) in which none having prior tested positive for the coronavirus got reinfected. The study authors concluded that “individuals who have had SARS-CoV-2 infection are unlikely to benefit from covid-19 vaccination.”. As well another Washington University study found that even a mild covid infection resulted in long-lasting immunity.

  • People who recovered from a natural infection are reported as having immunity that is 40 times more durable at preventing hospitalization from future variants.
  • I offer a Wall Street Journal article that contains links to 15 studies supporting natural immunity.
  • Here is an article which references a study performed by Johns Hopkins on Natural Immunity, declaring it “Fauci’s worst nightmare”, and which reports that “If you had a positive COVID test in the past, then you had a 99.3 percent chance of having circulating antibodies against COVID, and those antibodies were present up to 20 months, nearly two years after the infection.”, as explained by Dr. Marty Makary on the TV Show “Washington Watch“. Another video here.
  • The National Review reported that Germany has started treating those having natural immunity the same as those having been vaccinated. Some larger medical centers, like Spectrum Health in Grand Rapids, in Michigan, USA, have already announced they will recognize natural immunity for their vaccine requirements.
  • In a June 30, 2021 appearance on Fox News, epidemiologist and cardiologist Dr. Peter McCullough pointed out that “It is very clear from the U.K. Technical Briefing published June 18 2021 that the vaccine provides no protection against the Delta variant.”. The reason for this is because the Delta variant contains three different mutations, all in the spike protein. This allows this variant to evade the immune responses in those who have received the prior vaccinations, but not those who have natural immunity, which is much broader. (Article)

US Florida Governor Ron DeSantis has questioned US President Biden’s COVID-19 vaccine mandates as “not following science” on the natural immunity people acquire from already being infected. During a press conference he states, “These mandates, this is not about science, because if it was about science, you would recognize the infection conferred immunity.”.

CORBEVAX

A new vaccine that uses older (but proven) technology called, “CORBEVAX” can be manufactured more easily than most, if not all, of the COVID-19 vaccines in use today. The vaccine should provide the ability for all of the countries around the world, particularly low-income countries, to produce and distribute this vaccine affordably, effectively, and safely. The researchers state, “It’s the same technology as the hepatitis B vaccine that’s been around for decades.”. Referencing older research, when the COVID-19 pandemic struck, the researchers dusted off their old technology and modified it for use against COVID-19, as the virus causing COVID-19 is quite similar to the virus causing SARS. The researchers point out that unlike mRNA vaccines from Pfizer and Moderna, and the viral vector vaccine from Johnson & Johnson, protein subunit vaccines like CORBEVAX have a track record. The vaccine only costs between USD $1.00 and $1.50 a dose.

The researchers tried to interest government officials with their solution but, “People were so fixated on innovation that nobody thought, ‘Hey, maybe we could use a low-cost, durable, easy-breezy vaccine that can vaccinate the whole world.'”. As they could not get any traction in the USA, the researchers gained some ground in India. Clinical trials showed they were right to be confident CORBEVAX would work – an unpublished study conducted in India involving 3,000 volunteers found the vaccine to be 90% effective in preventing disease cause by the original COVID-19 virus strain, and 80% against the delta variant. At the time of this writing it was still being tested against omicron. However, this vaccine received emergency use authorization from regulators in India, with an Indian vaccine manufacturer “Biological E Ltd” now manufacturing the vaccine. The company is producing 100 million doses per month, and has already sold 300 million doses to the Indian government.

But the really amazing benefit of this vaccine is that the researchers have made the intellectual property of this vaccine available to everybody. In contrast the makers of Pfizer and Moderna are not sharing their recipe.

The only apparent drawback to this vaccine is that it can’t be modified as quickly as mRNA vaccines, slowing release for new variants.

Ivermectin

It is sad that this solution received the negative press that it does not deserve. No, Ivermectin is not just a veterinary-grade treatment. Be careful suggesting that it not be suitable for humans, as a lot of antibiotics prescribed to people are also used throughout the animal kingdom – are you going to stop taking them too? I think we often forget that we are, after all, animals.

When prescribed for human use, the Nobel Prize-winning drug has actually shown promise. All the way back in April 2020, the journal Antiviral Research published an article touting ivermectin’s possible efficacy in inhibiting the virus.

I’d like to introduce you to the African Program for Onchocerciasis Control (APOC), which is a grouping of countries that took part in an “intensive Ivermectin mass campaign carried out to control onchocerciasis” (a parasitic tropical disease). The National Library of Medicine published research comparing COVID-19 mortality and infection rates in the participating APOC countries with those that had not. It was found that APOC countries had a 28 percent lower COVID-19 mortality rate and an 8 percent lower rate of infection than their non-APOC counterparts.

Another study published by the Tokyo Medical Center suggests a similar correlation. The Japanese study asked why Africa has had such low rates of COVID-19 infection. They postulated it could be due to the provisioning of Ivermectin. The researchers looked into thirty-one “onchocerciasis endemic” countries using “community-directed treatment with Ivermectin” comparing their COVID-19 statistics with twenty-two “non-endemic” countries, and found that the mortality rate was “significantly less” in the thirty-one nations with high Ivermectin use.

  • Covid-19 count in countries giving Ivermectin:
    • number of cases is 134.4 per 100,000 and 2.2 deaths per 100,000
  • COVID-19 count in countries not giving Ivermectin:
    • number of cases is 950.6 per 100,000 and 29.3 deaths per 100,000

Of course, one cannot directly conclude that Ivermectin is effective only on the basis of these results, however we can also not say that it is not helping.

A correction for the above source: despite the implication of the Twitter user who had posted video of the news conference we must correct that neither Ozaki nor the Tokyo Medical Association is affiliated with the Japanese government.

Chloroquine and Hydroxychloroquine

Below are a collective grouping of studies supporting that chloroquine and hydroxychloroquine can successfully treat COVID-19 infections. It was concluded that chloroquine and hydroxychloroquine have antiviral characteristics in vitro. The findings support the hypothesis that these drugs have efficacy in the treatment of COVID-19. These products are currently used for the treatment of malaria. Here is a Fox News article on the benefits of using Hydrochloroquine early into COVID-19. And here is a news brief outlinging what some of the more outspoken and controversial individuals at Fox News have been saying about Hydroxycholroquine – which makes you wonder if it was held back due to politics? Doesn’t say much for our politicians, if that’s the case – certainly not anyone I’d vote for.

High-Frequencies / Ultrasonics

Early into the COVID-19 outbreak (around December of 2020) I asked a simple question on a public website geared to connect civilians with scientists (of course, my question was removed):

“Back in 2008 an article was published advising that viruses can be killed using resonate frequencies. I would hope, therefore, that there is research moving forward towards curing COVID-19 using this technology? Unless I am misunderstanding something, this approach can be aligned with Dr. Royal Raymond Rife, who discovered this back in the 1930’s. I wonder why this is not being more seriously investigated?”

Additional links were offered: here and here. The background information on Royal R. Rife follows:

  • Around 100 years ago Royal R. Rife developed a device that used high frequencies to essentially vibrate different cells apart.
  • He discovered that you could use the device on a live person, and the frequency generated would not have any impact on any other types of cells or molecules in the affected area. The patient felt nothing while the machine destroyed the damaging cells in the body.
  • He had specified the specific frequencies of various illnesses and was curing people of them.
  • Unfortunately his competition (pharmaceutical companies) worked to discredit him, and upon his death all of the machines were all purchased and removed from the market.

Prior to my post being removed, I received some positive responses from scientists. Since then I noticed that some researchers have taken an active interest in this idea:

Question: I wonder why we are not hearing about these alternate solutions?

Bromelain rich pineapple stem may be used as an antiviral against COVID-19

Here is a research demonstrating that bromelain (isolated from pineapple stem and used as a dietary supplement) treatment diminishes the expression of ACE-2. They published that, altogether their research suggests that bromelain or bromelain rich pineapple stem may be used as an antiviral against COVID-19. Another supporting article here.

And More!

Of course, there are many more possible solutions. I bet you never even heard of most (or any) of the above – I wonder why? An issue that encompasses the world, yet all we hear about are these mRNA solutions… Here is a research paper advising of just a few more possible solutions: a review of the proposed pharmacological treatments.

Read the next section, “Contraversies“.